PAVmed Inc. shareholders have approved an amendment to the company's certificate of incorporation authorizing a reverse stock split at a ratio between 1-for-10 and 1-for-30, with the final ratio to be determined by the board of directors. The amendment also reduces the number of authorized common shares from 250 million to 25 million. The board plans to implement the reverse split and authorized share reduction by filing a certificate of amendment with the Delaware Secretary of State.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PAVmed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-026368), on December 05, 2025, and is solely responsible for the information contained therein.